946 related articles for article (PubMed ID: 12016041)
21. [Preservation of the larynx in advanced cancer--experiences at the Oncology Department, Rambam Medical Center, Haifa].
Rosenblatt E; Siegelmann-Danieli N; Zidan J; Haim N; Kuten A
Harefuah; 2000 Oct; 139(7-8):271-4, 326. PubMed ID: 11062969
[TBL] [Abstract][Full Text] [Related]
22. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T
J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441
[TBL] [Abstract][Full Text] [Related]
23. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
[TBL] [Abstract][Full Text] [Related]
24. Locally advanced (stage III and IV) head and neck cancer: Westmead Hospital experience.
Turner SL; Kalnins I; Gebski V; Tiver KW
Aust N Z J Surg; 1991 Oct; 61(10):744-52. PubMed ID: 1929974
[TBL] [Abstract][Full Text] [Related]
25. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
26. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
27. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
Lefebvre JL; Pointreau Y; Rolland F; Alfonsi M; Baudoux A; Sire C; de Raucourt D; Malard O; Degardin M; Tuchais C; Blot E; Rives M; Reyt E; Tourani JM; Geoffrois L; Peyrade F; Guichard F; Chevalier D; Babin E; Lang P; Janot F; Calais G; Garaud P; Bardet E
J Clin Oncol; 2013 Mar; 31(7):853-9. PubMed ID: 23341517
[TBL] [Abstract][Full Text] [Related]
30. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
[TBL] [Abstract][Full Text] [Related]
31. [Perioperative chemotherapy of squamous cell carcinoma of the hypopharynx].
Mamelle G; Domenge C; Eschwège F; Leridant AM; Luboinski B; Wibault P
Bull Cancer Radiother; 1996; 83(2):115-7. PubMed ID: 8688218
[TBL] [Abstract][Full Text] [Related]
32. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
34. [Retrospective study of 139 cases of epidermoid carcinoma of the upper respiratory and digestive tracts treated by induction chemotherapy with cisplatin-5FU. Influence of the result on the therapeutic protocol].
Mahé E; Filleul A; Sachwald J; Meeus L; Bertrand F; Berlie J; Banal A; Zojaji A; Tubiana-Hulin M
Ann Otolaryngol Chir Cervicofac; 1992; 109(8):410-6. PubMed ID: 1304101
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
[TBL] [Abstract][Full Text] [Related]
36. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
[TBL] [Abstract][Full Text] [Related]
37. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant therapy for organ preservation in head and neck cancer.
Urba SG; Wolf GT; Bradford CR; Thornton AF; Eisbruch A; Terrell JE; Carpenter V; Miller T; Tang G; Strawderman M
Laryngoscope; 2000 Dec; 110(12):2074-80. PubMed ID: 11129024
[TBL] [Abstract][Full Text] [Related]
39. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
40. [Induction chemotherapy and laryngeal preservation in pharyngolaryngeal carcinomas. Study of a 124 serie's patients and patient's follow up with laryngeal preservation].
Bessède JP; Vinh D; Genet D; Khalifa N; Aubry K; Rhein B; Orsel S; Tubiana-Mathieu N; Clavère P
Rev Laryngol Otol Rhinol (Bord); 2004; 125(2):81-8. PubMed ID: 15462166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
